Posted by Michael Wonder on 04 Aug 2024
How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe
1 August 2024 - This paper elicited the opinions of European stakeholders on how HTA can be improved to facilitate access.
Our results reiterate that increased transparency during HTA and the decision-making processes is essential; the use of and reliance on new evidence generation such as real world evidence can optimise the availability of medicines; and better collaborations between regulatory institutions within and between countries are paramount for better access to medicines.
